Cargando…
Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo
The inflammatory bowel diseases (IBD) are complex immune-mediated inflammatory diseases that are associated with significant morbidity around the world. As our understanding of IBD, and other immune-mediated inflammatory diseases, advances the number of therapeutic targets has increased which has ra...
Autores principales: | Turbayne, Alexander Keith, Sparrow, Miles Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652213/ https://www.ncbi.nlm.nih.gov/pubmed/36242689 http://dx.doi.org/10.1007/s10620-022-07719-x |
Ejemplares similares
-
Histological remission of autoimmune hepatitis after the addition of allopurinol and azathioprine dose reduction
por: Guedes, Ana Luiza Vilar, et al.
Publicado: (2017) -
Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone
por: Coulthard, Sally A., et al.
Publicado: (2017) -
Prosthetic urology: past, present, and future
por: Tsambarlis, Peter N, et al.
Publicado: (2019) -
Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial
por: Kiszka-Kanowitz, Marianne, et al.
Publicado: (2022) -
Azathioprine-induced severe anemia potentiated by the concurrent use of allopurinol
por: Madrazo, Lorenzo, et al.
Publicado: (2021)